Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trial
Margaret Ross, Ravi Iyer, M.l. Williams, Mark Boughey, Clare O’callaghan, Richard Hiscock, Justin Dwyer
General Hospital Psychiatry August 12, 2025 DOI: 10.1016/j.genhosppsych.2025.08.001 via OpenAlex
Summary
AI-generated from the abstractPsilocybin-assisted psychotherapy appears safe and may provide lasting relief from depression and anxiety for people facing a life-threatening illness.
Study at a glance
| Characteristics | Randomized controlled trial Peer reviewed |
|---|---|
| Population | Individuals with a life-threatening illness |
| Intervention | Psilocybin-assisted psychotherapy |
| Topics | Anxiety Psilocybin |
| Keywords | Randomized controlled trial Psychotherapist Depression economics |
| Citations | 13 |
| Key finding | Psilocybin-assisted psychotherapy appears safe and may offer durable relief from depression and anxiety in individuals with a life-threatening illness. |
Abstract
Psilocybin-assisted psychotherapy appears safe and may offer durable relief from depression and anxiety in individuals with a life-threatening illness.